Recombinant human TNF-binding protein-1 (rhTBP-1) treatment delays both symptoms progression and motor neuron loss in the wobbler mouse
Articolo
Data di Pubblicazione:
2008
Citazione:
Recombinant human TNF-binding protein-1 (rhTBP-1) treatment delays both symptoms progression and motor neuron loss in the wobbler mouse / P. Bigini, M. Repici, G. Cantarella, E. Fumagalli, S. Barbera, A. Cagnotto, A. De Luigi, R. Tonelli, R. Bernardini, T. Borsello, T. Mennini. - In: NEUROBIOLOGY OF DISEASE. - ISSN 0969-9961. - 29:3(2008 Mar), pp. 465-476.
Abstract:
TNF-alpha overexpression may contribute to motor neuron death in amyotrophic lateral sclerosis (ALS). We investigated the intracellular pathway associated with TNF-alpha in the wobbler mouse, a murine model of ALS, at the onset of symptoms. TNF-alpha and TNFR1 overexpression and JNK/p38MAPK phosphorylation occurred in neurons and microglia in early symptomatic mice, suggesting that this activation may contribute to motor neuron damage. The involvement of TNF-alpha was further confirmed by the protective effect of treatment with rhTNF-alpha binding protein (rhTBP-1) from 4 to 9 weeks of age. rhTBP-1 reduced the progression of symptoms, motor neuron loss, gliosis and JNK/p38MAPK phosphorylation in wobbler mice, but did not reduce TNF-alpha and TNFR1 levels. rhTBP-1 might possibly bind TNF-alpha and reduce the downstream phosphorylation of two main effectors of the neuroinflammatory response, p38MAPK and JNK.
Tipologia IRIS:
01 - Articolo su periodico
Keywords:
TNFR1; rhTBP-1; p38MAPK; JNK; motor neuron degeneration; wobbler; amyotrophic lateral sclerosis; TNF-alpha; glial activation
Elenco autori:
P. Bigini, M. Repici, G. Cantarella, E. Fumagalli, S. Barbera, A. Cagnotto, A. De Luigi, R. Tonelli, R. Bernardini, T. Borsello, T. Mennini
Link alla scheda completa: